Cerevel Therapeutics: Funding, Investors & Team (Sep 2026)
Cerevel Therapeutics is dedicated to unraveling the mysteries of the brain to treat neuroscience diseases. The company is tackling neuroscience diseases with a differentiated approach that combines expertise in neurocircuitry with a focus on receptor selectivity. Cerevel Therapeutics has a diversified pipeline comprising five clinical-stage investigational therapies and several preclinical compounds with the potential to treat a range of neuroscience diseases, including schizophrenia, epilepsy, Parkinson’s disease and substance use disorder.
Cerevel Therapeutics has raised $300M across 1 funding round on record, the most recent a Post-IPO Debt of $300M announced in Aug 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Cerevel Therapeutics Company Profile and Key Stats
Latest funding round on record: Aug 2022.
Cerevel Therapeutics Funding Rounds
Cerevel Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Cerevel Therapeutics Funding Compared to Other Biotechnology Startups
Cerevel Therapeutics' latest round of $300M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Cerevel Therapeutics in Biotechnology and Boston
Companies Similar to Cerevel Therapeutics
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Cerevel Therapeutics Funding FAQs
What does Cerevel Therapeutics do?
Cerevel Therapeutics is dedicated to unraveling the mysteries of the brain to treat neuroscience diseases. The company is tackling neuroscience diseases with a differentiated approach that combines expertise in neurocircuitry with a focus on receptor selectivity. Cerevel Therapeutics has a diversified pipeline comprising five clinical-stage investigational therapies and several preclinical compounds with the potential to treat a range of neuroscience diseases, including schizophrenia, epilepsy, Parkinson’s disease and substance use disorder.
How much funding has Cerevel Therapeutics raised?
Cerevel Therapeutics has raised $300M across 1 round on record. The most recent is a Post-IPO Debt of $300M announced in Aug 2022.
When did Cerevel Therapeutics last raise funding?
Cerevel Therapeutics' most recent funding round on record is a Post-IPO Debt of $300M, announced in Aug 2022.
Who is the CEO of Cerevel Therapeutics?
Tony Coles is listed as CEO at Cerevel Therapeutics.
Where is Cerevel Therapeutics headquartered?
Cerevel Therapeutics is based in Boston, Massachusetts, United States.
How many employees does Cerevel Therapeutics have?
Cerevel Therapeutics is in the 251-500 employee band.
How does Cerevel Therapeutics' funding compare to other Biotechnology startups?
Cerevel Therapeutics' latest round of $300M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Cerevel Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Cerevel Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.